{"id":3574,"date":"2020-10-26T20:05:37","date_gmt":"2020-10-26T20:05:37","guid":{"rendered":"https:\/\/gpsites.co\/health\/?page_id=3574"},"modified":"2022-05-22T04:25:22","modified_gmt":"2022-05-22T04:25:22","slug":"services","status":"publish","type":"page","link":"https:\/\/synthonicsinc.com\/?page_id=3574","title":{"rendered":"About Synthonics"},"content":{"rendered":"<div class=\"gb-container gb-container-613ced2e\"><div class=\"gb-inside-container\">\n<div class=\"gb-grid-wrapper gb-grid-wrapper-362daeb1\">\n<div class=\"gb-grid-column gb-grid-column-27a0e383\"><div class=\"gb-container gb-container-27a0e383\"><div class=\"gb-inside-container\">\n\n<p class=\"gb-headline gb-headline-25158df7\"><span class=\"gb-icon\"><svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" viewBox=\"0 0 36.7 3\"><path d=\"M0 0h36.7v3H0z\"><\/path><\/svg><\/span><span class=\"gb-headline-text\">About Synthonics<\/span><\/p>\n\n\n\n<h2 class=\"gb-headline gb-headline-e923e090 gb-headline-text\">Synthonics is the global leader in intellectual property and expertise of the Metal Coordination Pharmaceutical  (MCP) space.<\/h2>\n\n\n\n<p><\/p>\n\n\n\n<p><\/p>\n\n\n\n<p><\/p>\n\n\n\n<p><\/p>\n\n\n\n<p><\/p>\n\n<\/div><\/div><\/div>\n\n<div class=\"gb-grid-column gb-grid-column-afc3afdf\"><div class=\"gb-container gb-container-afc3afdf\"><div class=\"gb-inside-container\">\n\n<p>Synthonics, Inc. is a privately-held specialty pharmaceutical company focused on the discovery and development of patentable drugs that incorporate our proprietary metal coordination chemistry. We bind metals to known pharmaceutical agents to create new products that are better absorbed and delivered and have greater therapeutic benefits than their predecessors. We patent drugs incorporating our chemistry as new compositions of matter.<\/p>\n\n\n\n<p>Our products under development are designed to deliver best in class treatment for conditions such as Parkinson\u2019s disease and hypothyroidism.<\/p>\n\n\n\n<p>We are headquartered in the Virginia Tech Corporate Research Center in Blacksburg, Virginia.<\/p>\n\n<\/div><\/div><\/div>\n<\/div>\n<\/div><\/div>\n\n<div class=\"gb-container gb-container-5bfca8d8\"><div class=\"gb-inside-container\">\n\n<h3 class=\"gb-headline gb-headline-136b6ef2\"><span class=\"gb-icon\"><svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" viewBox=\"0 0 36.7 3\"><path d=\"M0 0h36.7v3H0z\"><\/path><\/svg><\/span><span class=\"gb-headline-text\">Where will MCP be in the future?<\/span><\/h3>\n\n\n<div class=\"gb-grid-wrapper gb-grid-wrapper-c6f348c7\">\n<div class=\"gb-grid-column gb-grid-column-6fb26337\"><div class=\"gb-container gb-container-6fb26337\"><div class=\"gb-inside-container\">\n\n<figure class=\"wp-block-image size-full grey-shadow img\"><img loading=\"lazy\" decoding=\"async\" width=\"600\" height=\"450\" src=\"https:\/\/synthonicsinc.com\/wp-content\/uploads\/2020\/10\/family-practice-1.jpg\" alt=\"\" class=\"wp-image-4366\" srcset=\"https:\/\/synthonicsinc.com\/wp-content\/uploads\/2020\/10\/family-practice-1.jpg 600w, https:\/\/synthonicsinc.com\/wp-content\/uploads\/2020\/10\/family-practice-1-300x225.jpg 300w\" sizes=\"auto, (max-width: 600px) 100vw, 600px\" \/><\/figure>\n\n\n\n<h4 class=\"gb-headline gb-headline-387b221d gb-headline-text\">Primary Care<\/h4>\n\n\n\n<p>From hypothyroidism and Parkinson&#8217;s to inflammatory bowel disorders and influenza, MCP&#8217;s ability to improve existing drugs will lead to wide applications. Please see our science and capabilities sections for more information.<\/p>\n\n<\/div><\/div><\/div>\n\n<div class=\"gb-grid-column gb-grid-column-fd3424cf\"><div class=\"gb-container gb-container-fd3424cf\"><div class=\"gb-inside-container\">\n\n<figure class=\"wp-block-image size-full is-resized grey-shadow img is-style-default\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/synthonicsinc.com\/wp-content\/uploads\/2022\/05\/qtq80-HZy3fa-e1653181972698.jpeg\" alt=\"\" class=\"wp-image-4812\" width=\"600\" height=\"450\" srcset=\"https:\/\/synthonicsinc.com\/wp-content\/uploads\/2022\/05\/qtq80-HZy3fa-e1653181972698.jpeg 600w, https:\/\/synthonicsinc.com\/wp-content\/uploads\/2022\/05\/qtq80-HZy3fa-e1653181972698-300x225.jpeg 300w\" sizes=\"auto, (max-width: 600px) 100vw, 600px\" \/><\/figure>\n\n\n\n<h4 class=\"gb-headline gb-headline-ecb5a3b5 gb-headline-text\">Cancer <\/h4>\n\n\n\n<p>The design of G4 binders using medical radiometals can be considered an attractive approach to explore DNA-targeted molecules in cancer theranostics. These nuclear medicine modalities have already made an enormous contribution to the diagnosis and treatment of cancer in the clinical onset, based on the use of appropriate radioactive compounds designated as radiopharmaceuticals (<a href=\"https:\/\/www.mdpi.com\/1424-8247\/14\/7\/605\/htm\" data-type=\"URL\" data-id=\"https:\/\/www.mdpi.com\/1424-8247\/14\/7\/605\/htm\">Carvalho &amp; colleagues<\/a>).<\/p>\n\n<\/div><\/div><\/div>\n\n<div class=\"gb-grid-column gb-grid-column-14ac2213\"><div class=\"gb-container gb-container-14ac2213\"><div class=\"gb-inside-container\">\n\n<figure class=\"wp-block-image size-full grey-shadow img\"><img loading=\"lazy\" decoding=\"async\" width=\"700\" height=\"467\" src=\"https:\/\/synthonicsinc.com\/wp-content\/uploads\/2022\/05\/qtq80-jThXLG-e1653191841447.jpeg\" alt=\"\" class=\"wp-image-4880\"\/><\/figure>\n\n\n\n<p><\/p>\n\n\n\n<h4 class=\"gb-headline gb-headline-94aa8199 gb-headline-text\">Outside of Medicine <\/h4>\n\n\n\n<p>Synthonics has developed a CBDa compound using MCP with child company <a href=\"https:\/\/chylocure.com\/\" data-type=\"URL\" data-id=\"https:\/\/chylocure.com\/\">Chylocure<\/a>. Other applications include metallo-caffeine: a \u201cmicro-reactor\u201d using metal impregnated biopolymers to selectively modify the absorption of caffeine from various energy drinks and related products.<\/p>\n\n<\/div><\/div><\/div>\n<\/div>\n\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-9d6595d7 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\"><\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\"><\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\"><\/div>\n<\/div>\n\n<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>Where will MCP be in the future?<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-3574","page","type-page","status-publish"],"_links":{"self":[{"href":"https:\/\/synthonicsinc.com\/index.php?rest_route=\/wp\/v2\/pages\/3574","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/synthonicsinc.com\/index.php?rest_route=\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/synthonicsinc.com\/index.php?rest_route=\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/synthonicsinc.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/synthonicsinc.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=3574"}],"version-history":[{"count":14,"href":"https:\/\/synthonicsinc.com\/index.php?rest_route=\/wp\/v2\/pages\/3574\/revisions"}],"predecessor-version":[{"id":4890,"href":"https:\/\/synthonicsinc.com\/index.php?rest_route=\/wp\/v2\/pages\/3574\/revisions\/4890"}],"wp:attachment":[{"href":"https:\/\/synthonicsinc.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=3574"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}